Innovation of some novel complexes based on 1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methanol ligand: Synthesis, structural elucidation DFT calculation and pharmaceutical studies

Novel divalent chelates of Co (II), Cu (II), Zn (II) and Ni (II) were prepared and described of the form [M (NTM)(CH3COO)2] where NTM = [1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methanol ligand. Elemental analyses, infrared red, 1H and 13CNMR, electronic, magnetic susceptibility, conductivity measurements and X-ray diffraction studies were used to assess our divalent metal complexes. Moreover, the stability and stoichiometry of the novel metal chelates were examined through the job's method in solutions. Correlation of all spectroscopic techniques states that NTM acts as a bi-dentate NO ligand to afford octahedral complex geometry for all the investigated metal chelates. Thermodynamic and kinetics factors for various thermal degradation phases were calculated. Moreover, B3LYP/LANL2DZ/6-311 g(d,p) theoretical study has been applied for estimating the MEP and quantum chemical reactivity descriptors of studied molecules. Moreover, the UV-Vis absorption spectra for the investigated molecules are predicted via the time-dependent DFT (TD-DFT) calculations. In addition, MOE- docking was tested on two different proteins, the receptor of (3HB5) breast cancer mutant oxidoreductase as well as the receptor of Glucosamine-6-phosphate synthase in complex with glucosamine-6- phosphate of (2VF5) E.coli and COVID-19 protease. The results recommended that the (NTMCo), (NTMNi), (NTMCu) and (NTMZn) complexes showed the highest inhibitory activity compared to the other NTM ligands as antimicrobial and breast cancer candidates. Furthermore, in-vitro anti-bacterial, anti-fungal, cytotoxic and anti-oxidant performances for the selected ligand as well as its chelates were studied. All metal chelates presented superiority, proceeding free organic ligand ineffective management, definitely NTMCu complex. Some novel metal complexes incorporating 1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methanol ligand were synthesized and their structures were elucidated by different analytical and computational techniques. Moreover, all the new compounds were tested in vitro against microbial strains, free radicals and cancer cell lines. Furthermore, pharmaceutical applications of the inspected compounds were confirmed by docking studies. image